Asthma and COPD are treated with dry powder inhalation technology.

We have developed an inhaler that is easy to use with a simple operating sequence: open-inhale-close. This device has been engineered to give visual, audible and tactile feedback of user steps, reassuring the patient that a dose has been delivered. Multiple doses are placed into one device, and each dose is individually separated. The fail-safe dose counter helps keep track of doses. Our device has been developed to comply with the current USFDA and European requirements for inhalers, which we believe, will make it easier for us to register across markets.

Since this device delivers a uniform dose over a range of patient effort, it can be used with confidence by the very young and the very old, as well at times when emergency medications have to be delivered .

Our product can be used to deliver currently marketed combinations of steroids and bronchodilators, as well as NCE steroid molecules.

Our intent is to design trials, validate, take through clinical trials, and launch in semiregulated markets by 2009.